Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase
- PMID: 18343708
- DOI: 10.1016/j.biocel.2008.01.029
Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase
Abstract
Disruption of cell-to-cell contacts, as observed in many pathophysiological conditions, prime hepatocytes for compensatory hyperplastic response that involves induction of several genes, including proto-oncogenes and other gene targets of beta-catenin signaling pathway. By using cultured hepatocytes and experimental models of adherens junction disruption we have investigated changes in beta-catenin subcellular localization and their relationships with inducible nitric oxide synthase (iNOS) expression. Two experimental models were employed: (a) rat hepatocytes obtained by collagenase liver perfusion within the first 48 h of culture; (b) 48-h old cultured hepatocytes, transiently transfected or not with a plasmid encoding for dominant/negative inhibitory kappa B-alpha, exposed to ethylene glycol-bis-(2-aminoethylether)-N,N,N',N'-tetraacetic acid/LiCl treatment. beta-Catenin signaling and cellular localization, iNOS expression and nuclear factor kappaB involvement, were investigated using morphological, cell and molecular biology techniques. E-cadherin-mediated disruption of cell-to-cell contacts induces early beta-catenin translocation from membrane to cytoplasm and nuclear compartments, events that are followed by up-regulation of c-myc, cyclin D1 and beta-transducin repeat-containing protein expression. This, in turn, resulted eventually in iNOS induction that was mechanistically related to nuclear factor kappaB activation, as unequivocally shown in cells expressing dominant negative inhibitory kappa B-alpha. Our data indicate that E-cadherin disassembly and concomitant inactivation of glycogen synthase kinase-3beta result in nuclear factor kappaB-dependent induction of iNOS in hepatocytes.
Similar articles
-
Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.Cancer Res. 2009 May 1;69(9):3764-71. doi: 10.1158/0008-5472.CAN-09-0014. Epub 2009 Apr 21. Cancer Res. 2009. PMID: 19383900
-
Hepatic ischemia/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression.Shock. 2006 Aug;26(2):162-8. doi: 10.1097/01.shk.0000223130.87382.73. Shock. 2006. PMID: 16878024
-
[Glutamine inhibits interleukin-1beta induced nitric oxide production and inducible nitric oxide synthase expression: experiment with cultured rat hepatocytes].Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):695-8. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19595066 Chinese.
-
Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver.Prog Histochem Cytochem. 2007;41(4):201-66. doi: 10.1016/j.proghi.2006.12.001. Epub 2007 Feb 8. Prog Histochem Cytochem. 2007. PMID: 17368308 Review.
-
Lactosylceramide: a lipid second messenger in neuroinflammatory disease.J Neurochem. 2007 Nov;103 Suppl 1:180-91. doi: 10.1111/j.1471-4159.2007.04822.x. J Neurochem. 2007. PMID: 17986153 Review.
Cited by
-
Regulation of apoptosis and innate immune stimuli in inflammation-induced preterm labor.J Immunol. 2013 Dec 1;191(11):5702-13. doi: 10.4049/jimmunol.1301604. Epub 2013 Oct 25. J Immunol. 2013. PMID: 24163412 Free PMC article.
-
Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway.J Exp Clin Cancer Res. 2019 Jul 22;38(1):323. doi: 10.1186/s13046-019-1320-y. J Exp Clin Cancer Res. 2019. PMID: 31331376 Free PMC article. Review.
-
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation.Front Immunol. 2016 Sep 22;7:378. doi: 10.3389/fimmu.2016.00378. eCollection 2016. Front Immunol. 2016. PMID: 27713747 Free PMC article. Review.
-
Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.Front Immunol. 2018 Apr 13;9:745. doi: 10.3389/fimmu.2018.00745. eCollection 2018. Front Immunol. 2018. PMID: 29706964 Free PMC article. Review.
-
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.Cells. 2019 Jul 15;8(7):726. doi: 10.3390/cells8070726. Cells. 2019. PMID: 31311204 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous